CANF Stock Summary and Trading Ideas (Can Fite Biopharma | AMEX:CANF)

Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and related conditions. It has a pipeline of proprietary drug candidates in Phase II and Phase III clinical development. The company's platform targets the A3 adenosine receptor (A3AR), which is more expressed in inflammatory and cancerous cells than in normal cells. Its pipeline drugs include Namodenoson, Piclidenoson, CF602, and Cannabinoids.

What symbol and exchange does Can Fite Biopharma shares trade?

Can Fite Biopharma trades on the AMEX stock market under the symbol CANF.

What is Can Fite Biopharma stock price doing today?

As of January 22, 2026, CANF stock price climbed to $4.16 with 94,049 million shares trading.

What is Can Fite Biopharma's Beta?

CANF has a beta of 2.34, meaning it tends to be more sensitive to market movements. CANF has a correlation of 0.02 to the broad based SPY ETF.

How much is Can Fite Biopharma worth?

CANF has a market cap of $3.55 million. This is considered a Sub-Micro Cap stock.

What is the highest and lowest price Can Fite Biopharma traded in the last 3 year period?

In the last 3 years, CANF traded as high as $5.36 and as low as $.17.

Is Can Fite Biopharma (CANF) a good investment?

CANF has outperformed the market in the last year with a return of +163.3%, while the SPY ETF gained +15.5%. In the last 3 month period, CANF beat the market returning +723.6%, while SPY returned +2.9%. However, in the most recent 2 weeks CANF has underperformed the stock market by returning -11.7%, while SPY returned -0.1%.

What are the support and resistance levels for Can Fite Biopharma (CANF)?

CANF support price is $3.70 and resistance is $4.46 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CANF shares will trade within this expected range on the day.